Issue 8/2013
Content (15 Articles)
Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy
Claudia Maletzki, Michael Linnebacher, Rajkumar Savai, Uwe Hobohm
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
Michael A. Morse, Arvind Chaudhry, Elizabeth S. Gabitzsch, Amy C. Hobeika, Takuya Osada, Timothy M. Clay, Andrea Amalfitano, Bruce K. Burnett, Gayathri R. Devi, David S. Hsu, Younong Xu, Stephanie Balcaitis, Rajesh Dua, Susan Nguyen, Joseph P. Balint Jr., Frank R. Jones, H. Kim Lyerly
Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the Hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival
Richard K. Yang, Nicholas A. Kalogriopoulos, Alexander L. Rakhmilevich, Erik A. Ranheim, Songwon Seo, KyungMann Kim, Kory L. Alderson, Jacek Gan, Ralph A. Reisfeld, Stephen D. Gillies, Jacquelyn A. Hank, Paul M. Sondel
The chemotherapeutic agent topotecan differentially modulates the phenotype and function of dendritic cells
Stefanie Trojandt, Diana Knies, Stefanie Pektor, Sandra Ritz, Volker Mailänder, Stephan Grabbe, Angelika B. Reske-Kunz, Matthias Bros
A case of spontaneous systemic immunity to melanoma associated with cure after amputation for extensive regional recurrence
Joshua M. Judge, Louis B. Brill II, Kelly T. Smith, Donna H. Deacon, James W. Patterson, William W. Grosh, Achim A. Jungbluth, Sacha Gnjatic, Craig L. Slingluff Jr.
Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK
Carol Inatsuka, Yi Yang, Ekram Gad, Lauren Rastetter, Mary L. Disis, Hailing Lu
TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells
Ryan M. Stephenson, Chwee Ming Lim, Maura Matthews, Gregory Dietsch, Robert Hershberg, Robert L. Ferris
A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells
Dhifaf Sarhan, Erik Wennerberg, Padraig D’Arcy, Deepthy Gurajada, Stig Linder, Andreas Lundqvist
Evaluating combinations of costimulatory antibody–ligand fusion proteins for targeted cancer immunotherapy
Nora Hornig, Katharina Reinhardt, Vanessa Kermer, Roland E. Kontermann, Dafne Müller
Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients
Willemijn Hobo, Leonie Strobbe, Frans Maas, Hanny Fredrix, Annelies Greupink-Draaisma, Ben Esendam, Theo de Witte, Frank Preijers, Henriëtte Levenga, Bas van Rees, Reinier Raymakers, Nicolaas Schaap, Harry Dolstra
Avidity of onconeural antibodies is of clinical relevance
Cecilie Totland, Ming Ying, Mette Haugen, Kibret Mazengia, Anette Storstein, Jan Aarseth, Aurora Martinez, Christian Vedeler
Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies
Girja S. Shukla, David N. Krag, Elena N. Peletskaya, Stephanie C. Pero, Yu-Jing Sun, Chelsea L. Carman, Laurence E. McCahill, Thomas A. Roland
Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours
Agnieszka Szala, Sambor Sawicki, Anna St. Swierzko, Janusz Szemraj, Marcin Sniadecki, Mateusz Michalski, Andrzej Kaluzynski, Jolanta Lukasiewicz, Anna Maciejewska, Dariusz Wydra, David C. Kilpatrick, Misao Matsushita, Maciej Cedzynski
Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
Fumitaka Arihara, Eishiro Mizukoshi, Masaaki Kitahara, Yoshiko Takata, Kuniaki Arai, Tatsuya Yamashita, Yasunari Nakamoto, Shuichi Kaneko
The Twelfth International Conference on Progress in Vaccination Against Cancer (PIVAC 12), Nottingham, UK, 11–13 September 2012: insights into the dynamics of anti-tumour immunity and the development of cancer vaccines
Sumanjeet Kaur Malhi, Jaimy Saif, Jayakumar Narayanan Vadakekolathu